Sox18Mhdadcc1/Sox18+
C3HeB/FeJ-Sox18Mhdadcc1/Ieg
|
darkened coat color |
J:81301
|
Sox18Mhdadcc1/Sox18Mhdadcc1
C3HeB/FeJ-Sox18Mhdadcc1/Ieg
|
abnormal hair growth |
J:81301
|
darkened coat color |
J:81301
|
sparse hair |
J:81301
|
Sox18Ra-J/Sox18+
involves: C3H/HeSnJ
|
darkened coat color |
J:30359
|
retarded hair growth |
J:30359
|
short vibrissae |
J:30359
|
sparse hair |
J:30359
|
Sox18Ra-J/Sox18Ra-J
involves: C3H/HeSnJ
|
abnormal vibrissa number |
J:30359
|
decreased body size |
J:30359
|
hairless |
J:30359
|
neonatal lethality, incomplete penetrance |
J:30359
|
Sox18Ra-Op/Sox18+
involves: C57BL/6J * DBA/2J
|
abnormal awl hair morphology |
J:260
|
abnormal hair follicle morphology |
J:279
|
abnormal hair growth |
J:260,
J:279
|
abnormal vibrissa morphology |
J:279
|
abnormal vibrissa number |
J:260
|
abnormal zigzag hair morphology |
J:279
|
absent auchene hairs |
J:260
|
cyanosis |
J:260
|
decreased body size |
J:260,
J:279
|
decreased zigzag hair amount |
J:260,
J:279
|
delayed hair appearance |
J:260,
J:279
|
distended abdomen |
J:279
|
edema |
J:260,
J:279
|
perinatal lethality, incomplete penetrance |
J:260,
J:279
|
postnatal lethality, incomplete penetrance |
J:260,
J:279
|
short vibrissae |
J:279
|
skin edema |
J:260
|
sparse hair |
J:260,
J:279
|
Sox18Ra-Op/Sox18Ra-Op
B6D2-Sox18Ra-Op/J
|
abnormal blood vessel morphology |
J:150211
|
abnormal lymphatic vessel morphology |
J:143564
|
abnormal pericyte morphology |
J:150211
|
abnormal vascular endothelial cell physiology |
J:150211
|
normal
cardiovascular system phenotype |
J:150211
|
edema |
J:150211
|
hematoma |
J:150211
|
hemorrhage |
J:150211
|
increased vascular endothelial cell number |
J:150211
|
lethality throughout fetal growth and development, complete penetrance |
J:143564,
J:150211
|
skin edema |
J:143564,
J:150211
|
Sox18Ra-Op/Sox18Ra-Op
involves: C57BL/6J * DBA/2J
|
embryonic lethality, complete penetrance |
J:279
|
preweaning lethality, complete penetrance |
J:260
|
Sox18Ra/Sox18+
involves: AG/Cam
|
chylous ascites |
J:6220,
J:13089
|
decreased total body fat amount |
J:13089
|
intestinal fibrosis |
J:13089
|
retarded hair growth |
J:13089
|
Sox18Ra/Sox18+
Not Specified
|
abnormal hair follicle morphology |
J:12991
|
abnormal zigzag hair morphology |
J:86
|
absent auchene hairs |
J:86
|
chylous ascites |
J:13089
|
darkened coat color |
J:86
|
retarded hair growth |
J:86
|
sparse hair |
J:86
|
Sox18Ra/Sox18Ra
Not Specified
|
alopecia |
J:86
|
edema |
J:86
|
preweaning lethality, incomplete penetrance |
J:86
|
Sox18Ragl/Sox18+
involves: 129P3/J * C57BL/6J
|
chylous ascites |
J:83731
|
disheveled coat |
J:83731
|
edema |
J:83731
|
sparse hair |
J:83731
|
Sox18Ragl/Sox18Ragl
involves: 129P3/J * C57BL/6J
|
chylous ascites |
J:83731
|
edema |
J:83731
|
embryonic lethality, incomplete penetrance |
J:83731
|
hairless |
J:83731
|
neonatal lethality, complete penetrance |
J:83731
|
Sox18tm1(GFP/cre/ERT2)Pzg/Sox18+
involves: 129S7/SvEvBrd * C57BL/6J
|
no abnormal phenotype detected |
J:159099
|
Sox18tm1.1(KOMP)Vlcg/Sox18tm1.1(KOMP)Vlcg
C57BL/6N-Sox18tm1.1(KOMP)Vlcg/J
|
abnormal behavior |
J:211773
|
decreased thigmotaxis |
J:211773
|
increased circulating alkaline phosphatase level |
J:211773
|
increased circulating sodium level |
J:211773
|
increased mean corpuscular hemoglobin |
J:211773
|
Sox18tm1Koop/Sox18+
B6.129-Sox18tm1Koop
|
skin edema |
J:143564
|
Sox18tm1Koop/Sox18tm1Koop
B6.129-Sox18tm1Koop
|
abnormal lymphatic vessel morphology |
J:143564
|
lethality throughout fetal growth and development, complete penetrance |
J:143564
|
skin edema |
J:143564
|
Sox18tm1Koop/Sox18tm1Koop
involves: 129/Sv * CD-1
|
abnormal hair growth |
J:66010
|
darkened coat color |
J:66010
|